Skip to content 
AMM 283: Botox Parties: Beauty, Risks, and Sisterhood Revolution
December 03, 2024
This episode explores the latest FDA approval of Botox Cosmetic for treating platysma bands, expanding its use to four separate indications. Darin Messina, PhD, discusses the impact of this development on patient treatment options and industry marketing. The episode delves into the successful phase 3 clinical trials that supported this approval and highlights the benefits of this non-surgical method for improving appearance. Listeners will gain insight into how this advancement is shaping treatment protocols and setting new standards for injector training in the aesthetics field.
Quick Takes
- Botox Cosmetic now FDA approved for treating platysma bands
- Promises proven, safe, nonsurgical method for appearance improvement
- Backed by robust phase 3 clinical trials showing significant improvements
Episode Transcript
Today’s date, December 3rd, brings noteworthy news in the aesthetics world. Botox Cosmetic has received FDA approval for treating platysma bands, those pesky vertical bands between the jaw and neck that have perplexed many. This approval is significant as Botox becomes the first neurotoxin to cater to four indications: moderate to severe forehead lines, frown lines, crow’s feet, and now, platysma bands.
Darin Messina, PhD, senior vice president of Aesthetics R&D at Allergan Aesthetics, highlights that with this approval, patients now have a proven, safe, and nonsurgical method to improve their appearance. This development is poised to boost direct-to-consumer marketing, raising awareness and providing more treatment options tailored to individual severity levels.
The journey to this approval was backed by robust phase 3 clinical trials, showcasing remarkable improvements in appearance compared to a placebo. Studies indicate that a significant percentage of patients experienced a two-grade improvement in platysma band severity, with many expressing satisfaction with their post-treatment appearance.
In summary, this FDA approval not only enhances treatment protocols but also sets new standards for injector training, aiming to ensure safety and optimal results. Botox Cosmetic continues to innovate, offering broader choices for both practitioners and patients in aesthetic medicine.
